Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Universities join hands in developing literacy tests
2010-03-19

 
At the signing ceremony, from the left, are: Prof. Driekie Hay (Vice-Rector: Teaching and Learning), Prof. Albert Weideman (Head: Department of English) and Prof. Lucius Botes (Dean: Faculty of the Humanities).
Photo: Supplied


The development of academic literacy tests recently took a step into the future with the formal establishment of the Inter-institutional Centre for Language Development and Assessment (ICELDA).

ICELDA, under its first executive head, Prof. Albert Weideman, Head of the Department of English at the University of the Free State (UFS), is a cooperative venture between the multilingual Universities of Pretoria, North-West, Stellenbosch and the Free State.

It is dedicated to the development of reliable state-of-the-art academic literacy tests and currently makes 32 000 tests available to partnering universities annually.

Most notably, it has produced three of the most reliable academic literacy tests in the country. These include an Academic Listening Test and the Test of Academic Literacy Levels (TALL) for undergraduate students, with reliability levels that are more than 20% above international benchmarks.

“We are even more excited about our Test of Academic Literacy for Postgraduate Students (TALPS), which is already a crucial instrument in determining the literacy levels of postgraduate students at the Universities of the Free State, Pretoria and North-West,” said Prof. Weideman.

In addition, ICELDA is currently piloting studies for language tests for financial advisors, nurses, students of disaster management, as well as police studies at Unisa.

ICELDA will also collaborate with the Centre for English Language Communication (CELC) at the National University of Singapore.

“One of the undertakings I made on my visit to Singapore a year ago was that I would assist in every way I could with the building of joint expertise with CELC in language testing,” said Prof. Weideman.

“However, our focus will remain firmly on research.”

He said his goal was to employ the surpluses generated by selling tests to provide promising students with bursaries to stimulate further study and design of academic literacy and other language tests.

By drawing more researchers into the field, Weideman said, ICELDA could provide the capacity for developing reliable language tests that South Africa had always lacked.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
19 March 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept